Get started
Author

Е.А. Strebkova

Observed names: E. A. Strebkova, E. Strebkova, E.A. Strebkova, E.A. Strebkova Strebkova, Elena A. Strebkova, Е. А. Strebkova
ORCID: 0000-0002-0854-2264
Observed ORCID: 0000-0002-0854-2264
OpenAlex ID: A5009360941
The present and future disease burden of hepatitis C virus ( HCV ) infections with today's treatment paradigm – volume 2
2015 · A. Hatzakis, V. Chulanov, et al. · Journal of Viral Hepatitis · 125
PDF
Recent High Incidence of Fulminant Hepatitis in Samara, Russia: Molecular Analysis of Prevailing Hepatitis B and D Virus Strains
2000 · Erik Flodgren, Susanne Bengtsson, et al. · Journal of Clinical Microbiology · 98
Historical epidemiology of hepatitis C virus ( HCV ) in select countries – volume 2
2015 · V. Saraswat, S. Norris, et al. · Journal of Viral Hepatitis · 92
PDF
Strategies to manage hepatitis C virus ( HCV ) infection disease burden – volume 2
2015 · E. Gane, D. Kershenobich, et al. · Journal of Viral Hepatitis · 54
PDF
Experience of olokizumab use in COVID-19 patients
2020 · V. N. Antonov, G. L. Ignatova, et al. · Terapevticheskii arkhiv · 26
PDF
P1285 : Forecasting the disease burden of chronic hepatitis C in Russia
2015 · V. Chulanov, O. Sagalova, et al. · Journal of Hepatology · 6
Environmental exposure and element-by-element analysis of pandemic waves at the city level: Exposome algorithm for analysis of short-term temperature drops on surges in COVID-19-associated hospitalizations
2024 · A.N. Ishmatov, A.A. Bart, et al. · Sustainable Cities and Society · 4
Opportunities for microelimination of chronic hepatitis C virus infection in a paediatric population
2024 · Е.А. Strebkova, Е.S. Kindalova, et al. · Infekcionnye bolezni · 2
The HIV integrase inhibitor raltegravir as part of antiretroviral therapy schemes in patients with HIV infection and hepatitis C
2015 · A.V. Kravchenko, V.Ya. Aksenova, et al. · Infekcionnye bolezni · 2
Modern aspects of the use of local hyaluronic acid in musculoskeletal diseases
2023 · E.A. Strebkova Strebkova, L.I. Alekseeva Alekseeva · Therapy · 1
Efficacy and safety of Alflutop in the treatment of patients with osteoarthritis of the knee joints: multicenter open-label randomized clinical trial
2020 · E.P. Sharapova Sharapova, L.I. Alekseeva Alekseeva, et al. · Фарматека · 1
The real-world effectiveness of glecaprevir/pibrentasvir in HCV-infected adolescents 12–17 years of age in Russia (“DETI-2” study)
2023 · E.A. Strebkova, I.M. Khaertynova, et al. · Voprosy praktičeskoj pediatrii
Patients with CKD-5D and COVID infection. Individual organizational and clinical issues of therapy
2021 · P. V. Morinets, А. S. Navasardyan, et al. · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH)
PDF
Effectiveness of the algorithm for detecting cases of recent HIV-1 infection in the Russian Federation
2021 · A.V. Shlykova, D.E. Kireev, et al. · Infekcionnye bolezni
Possibilities of modern pangenotypic antiviral drugs for the treatment of chronic hepatitis C in patients on hemodialysis
2020 · M. Zubkin, O. Balkarova, et al. · Nephrology and Dialysis
Efficacy and safety of antiviral therapy with glecaprevir+ pibrentasvir for patients with chronic hepatitis c and chronic kidney disease
2018 · E.A. Strebkova Strebkova, O.V. Agafonova Agafonova, et al. · Kliničeskaâ nefrologiâ
An experience of treatment of patients with chronic hepatitis C/HIV co-infection using direct-acting antiviral drugs
2018 · A.A. Suzdaltsev, E.A. Strebkova, et al. · Infekcionnye bolezni
Clinico-epidemiological Characteristic of Patients With Chronic Viral Hepatitis in Samara Region
2014 · Е. А. Сокова, L. L. Popova, et al. · Международный научно-исследовательский журнал
Works count: 18
Citation count: 411
H-index: 6
I10-index: 5
Year
Topic
Type